Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 20 Sarcoma 7 Uterine Cervical Neoplasms 4 Rectal Neoplasms 4 Prostatic Neoplasms 4 Head and Neck Neoplasms 4 Melanoma 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Adenoma, Pleomorphic 1 Recurrence 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Oropharyngeal Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1

Interventions

Tranexamic Acid 12 Sodium Chloride 4 Misoprostol 4 Saline Solution 3 carbetocin 2 Tourniquets 2 Oxytocin 2 Enoxaparin 2 Endoscopic Mucosal Resection 2 Dalteparin 2 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Ultrasonography 1 Tinzaparin 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Lactate 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Palliative Care 1 Neuromuscular Blockade 1 N(4)-oleylcytosine arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemorrhage × Diathermy × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡